Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Levetiracetam NDC 44567-500 by Wg Critical Care, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
250 mg carton label - image 01
This is a prescription medication with National Drug Code (NDC) 44567-500-10. It comes in the form of 10 single-dose bags, each containing 50 mL of the medication. The concentration of the medication is 250mg/50mL or 5mg/mL. It is meant to be given through intravenous infusion.*
1000 mg carton label - image 02
This appears to be a label for a medication, specifically a 0.75% Sodium Chloride Injection with a concentration of 1000mg/100mL. The medication is meant for intravenous use only. The label also includes the product code "50210" and the text "Noc wse7". However, it is unclear what these phrases refer to.*
1500 mg carton label - image 03
This is a medication for intravenous infusion only, containing Levetiracetam and Sodium Chloride. It comes in single-dose bags of 10100 mil with a concentration of 1500 mg/100 ml. The National Drug Code (NDC) is 44567-503-10.*
Levetiracetam Structural Formula - image 04
500 mg carton label - image 05
This is a medication product labeled NDC 44567-501-10 containing Levetiracetam drug substance in a solution of 0.82% Sodium Chloride Injection having a concentration of 500 mg/100 mL or 5 mg/mL. The package consists of 10 x 100 mL Single-Dose Bags intended for Intravenous Infusion Only. The product is only available with a prescription (Rx only).*
Figure 2: Responder Rate (≥50% Reduction from Baseline) in Study 2: Period A - image 06
This is a table showing the percentage of patients who received a placebo or different doses of Levetiracetam medication. There are six rows that show percentages ranging from 45% to 5%. The table has three columns that show the type of medication given and the number of patients who received each medication. The footnote on the table indicates that statistically significant results were observed for the medication versus placebo.*
Figure 3: Responder Rate (≥50% Reduction from Baseline) in Study 3 - image 07
The text is describing a graph that shows the percentage of patients in different categories. There are percentages ranging from 0% to 45% with a note that reads "statistically significant versus placebo" at the bottom. Additionally, there are two categories labeled "Placebo" and "Levetiracetam 3000 mg/day" with the number of patients in each category (104 for Placebo and 180 for Levetiracetam). It is unclear what the graph shows exactly, but it appears to be related to medical treatment.*
Figure 4: Responder Rate (≥50% Reduction from Baseline) in PGTC Seizure Frequency per Week - image 08
The given text represents the percentage distribution of patients under Placebo and Levetiracetam treatment, where Levetiracetam showed a statistically significant difference over Placebo. However, without further context or information, it is not possible to determine the nature of the treatments or the condition being treated.*
Figure 1 - image 09
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.